Insider Selling: Vivo Ventures Vii, Llc Sells 299,609 Shares of MEI Pharma Stock (MEIP)
MEI Pharma (NASDAQ:MEIP) major shareholder Vivo Ventures Vii, Llc unloaded 299,609 shares of MEI Pharma stock on the open market in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $8.21, for a total transaction of $2,459,789.89. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
MEI Pharma (NASDAQ:MEIP) traded down 2.05% on Tuesday, hitting $8.13. 110,186 shares of the company’s stock traded hands. MEI Pharma has a one year low of $1.98 and a one year high of $13.20. The stock has a 50-day moving average of $7.41 and a 200-day moving average of $7.92. The company’s market cap is $139.2 million.
Several analysts have recently commented on the stock. Analysts at Stifel Nicolaus raised their price target on shares of MEI Pharma from $11.00 to $15.00 in a research note to investors on Tuesday, October 22nd. They now have a “buy” rating on the stock. Analysts at Roth Capital raised their price target on shares of MEI Pharma from $16.00 to $20.00 in a research note to investors on Monday, October 21st. They now have a “buy” rating on the stock.
MEI Pharma, Inc, formerly Marshall Edwards, Inc, is a development-stage oncology company. The Company is engaged in the development of drugs for the treatment of cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.